文献速递慢性肾脏病肾血管病与高血压

老年慢性肾脏病患者的血压控制、表观治疗抵抗与结局

Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease.
PubMed 文献 · Kidney Int Rep · 2016-10-31

该研究在4262名65岁以上社区居住人群中按血压控制状态和CKD分层,随访10年死亡与心血管事件。结果显示CKD合并控制或未控制高血压及aTRH的全因死亡风险升高,aTRH合并CKD者冠心病死亡风险超过参照组3倍,但CKD并未放大aTRH相关的卒中与冠脉事件风险。

要点

  • CKD合并aTRH者冠心病死亡风险超过参照组3倍。
  • 无论是否合并CKD,aTRH者卒中风险超过参照组2倍。
  • CKD合并控制高血压者其他原因心血管死亡风险为参照组2倍。

核心结论

  • 在该老年人群中,CKD似乎并未放大aTRH相关的卒中与冠脉事件风险。
  • CKD合并控制高血压者其他原因心血管死亡风险升高,其原因有待进一步研究。

研究设计与样本

  • 前瞻性社区队列研究,纳入4262名65岁以上社区居住个体,男性占40%。
  • 按血压控制状态和CKD(肾小球滤过率<60 ml/min/1.73m2)分层,评估10年全因死亡与心血管事件。

主要发现

  • 基线时19%患CKD,31.2%为≤3种降压药控制的高血压,62.3%为≤2种药物下≥140/90 mm Hg的未控制高血压,6.5%为aTRH。
  • 随访期间共1115例死亡(其中心血管死亡305例),274例新发非致死或致死性卒中或冠脉事件。
  • 无CKD且未控制高血压或aTRH者全因死亡校正风险比分别为0.86(0.74-1.01)和1.09(0.82-1.46)。
  • CKD合并控制高血压、未控制高血压或aTRH者全因死亡校正风险比分别为1.33(1.06-1.68)、1.14(0.93-1.39)和1.34(0.98-1.85)。
  • aTRH合并CKD者冠心病死亡风险超过参照组3倍;aTRH者无论是否合并CKD卒中风险超过2倍;CKD合并控制高血压者其他原因心血管死亡风险为2倍。

临床怎么用

  • 老年CKD患者应重视血压控制状态与aTRH评估,关注冠心病与卒中风险。
  • 对CKD合并控制高血压的老年患者,需关注其他原因心血管死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Chronic kidney disease (CKD) is often associated with poor hypertension control and treatment resistance, but whether CKD modifies the effect of hypertension control on outcomes is unknown. METHODS: We studied 10-year mortality and cardiovascular events according to hypertension control status and CKD (glomerular filtration rate <60 ml/min/1.73m2) in 4262 community-dwelling individuals (40% men) more than 65 years of age. RESULTS: At baseline, 19% had CKD, and 31.2% had controlled hypertension on ≤3 antihypertensive drugs, 62.3% uncontrolled hypertension ≥140/90 mm Hg on ≤2 drugs, and 6.5% apparent treatment-resistant hypertension (aTRH) ≥140/90 mm Hg with ≥3 drugs or use of ≥4 drugs regardless of level. There were 1115 deaths (305 total cardiovascular deaths) and 274 incident nonfatal or fatal strokes or coronary events. Compared to the reference group (controlled hypertension and no CKD), participants without CKD and with uncontrolled hypertension or aTRH had adjusted hazard ratios for all-cause mortality of 0.86 (0.74-1.01) and 1.09 (0.82-1.46), and those with CKD and controlled or uncontrolled hypertension, or aTRH, of 1.33 (1.06-1.68), 1.14 (0.93-1.39), and 1.34 (0.98-1.85), respectively. Participants with aTRH and CKD had a risk of coronary death more than 3 times higher than that of the reference group; participants with aTHR, with or without CKD, had a risk of stroke more than twice as high, and those with CKD but controlled hypertension a 2 times higher risk for cardiovascular deaths from other causes. DISCUSSION: CKD does not appear to amplify the risk of stroke and coronary events associated with aTRH in this older population. The reasons for excess cardiovascular mortality from other causes associated with controlled hypertension require further study.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Kaboré J, Metzger M, Helmer C, et al. Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease. Kidney Int Rep. 2016. PMID: 29142956. doi:10.1016/j.ekir.2016.10.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。